Recombinant human serum albumin (OsrHSA) has emerged as a significant innovation in the field of biopharmaceuticals, presenting promising breakthroughs throughout many healthcare and industrial programs. With its structural similarity to Normally derived human serum albumin, OsrHSA provides a safer, much more reliable alternative for therapeutic us